Philadelphia, PA, United States of America

Andy J Minn

This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: University of Pennsylvania, Novartis Ag, The United States Government. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andy J Minn. Retrieved from https://idiyas.com/inventor/andy-j-minn-l105m8s0

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 66.7

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Andy J Minn

Introduction

Andy J Minn is a prominent inventor based in Philadelphia, PA. He has made significant strides in the field of medical research, particularly in cancer treatment. His work focuses on enhancing immune responses through innovative therapies.

Latest Patents

Minn holds a patent for "Immune-enhancing RNAs for combination with chimeric antigen receptor therapy." This invention provides compositions and methods for treating diseases such as cancer. It also relates to a method of administering chimeric antigen receptor (CAR) therapy alongside an additional therapeutic agent. He has 1 patent to his name.

Career Highlights

Throughout his career, Andy J Minn has worked with esteemed organizations such as the University of Pennsylvania and Novartis AG. His contributions to these institutions have been pivotal in advancing cancer therapies and improving patient outcomes.

Collaborations

Minn has collaborated with notable colleagues, including Lexus R Johnson and Carl H June. Their combined expertise has fostered innovative approaches to cancer treatment.

Conclusion

Andy J Minn's work exemplifies the impact of innovative research in the medical field. His contributions continue to pave the way for advancements in cancer therapies and patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…